. Genmab Files for $500M U.S. IPO Seeking to Launch a Proprietary Treatment by 2025 httpow.lyuWG350urYfjÂpic.twitter.com5HI9azhWjP

. @Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary Treatment by 2025: http://ow.ly/uWG350urYfj pic.twitter.com/5HI9azhWjP

16:25 EDT 1 Jun 2019 | Genetic Engineering News

. @Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary Treatment by 2025: http://ow.ly/uWG350urYfj  pic.twitter.com/5HI9azhWjP

More From BioPortfolio on ". @Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary Treatment by 2025: http://ow.ly/uWG350urYfj pic.twitter.com/5HI9azhWjP"